CARDIOLOGIST Trial: Artificial Intelligence Enabled Electrocardiogram for Atrial Fibrillation Detection

NACompletedINTERVENTIONAL
Enrollment

25,732

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

January 31, 2023

Conditions
Atrial Fibrillation New Onset
Interventions
OTHER

AI-enabled ECG-based Screening Tool

Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-ECG result was positive or negative. The system will send a message to corresponding physicians if positive finding.

Trial Locations (1)

114

National Defense Medical Center, Taipei

All Listed Sponsors
lead

National Defense Medical Center, Taiwan

OTHER

NCT05127460 - CARDIOLOGIST Trial: Artificial Intelligence Enabled Electrocardiogram for Atrial Fibrillation Detection | Biotech Hunter | Biotech Hunter